Neuroblastoma is a rare childhood cancer that develops from nerve tissue, most commonly affecting very young children. Understanding the disease progression, long-term complications, and ways to support both patients and families through clinical trials and daily life is essential for navigating this challenging diagnosis.
Prognosis and What to Expect
When a child is diagnosed with neuroblastoma, one of the first questions that weighs heavily on parents’ minds is about the future. The outlook for children with neuroblastoma can vary significantly depending on several important factors. Age at the time of diagnosis plays a crucial role in determining what lies ahead. Children diagnosed before they turn 18 months old generally have a better chance of successful treatment outcomes compared to older children. In fact, survival rates for infants diagnosed before their first birthday have improved dramatically, reaching as high as 93% for five-year survival in recent decades.[13]
The stage of the disease at diagnosis is another critical factor that shapes expectations. Neuroblastoma is classified into different stages based on how far the cancer has spread and whether certain high-risk features are present. Low-risk neuroblastomas often have excellent prognosis, with cure rates reaching up to 92% in some groups.[9] These are typically smaller tumors that have not spread extensively and lack certain genetic changes that make cancer more aggressive. Children in this category may need minimal treatment, and in some remarkable cases, the tumor may even disappear on its own without any medical intervention.
Intermediate-risk cases fall somewhere in the middle and typically require moderate levels of treatment. However, high-risk neuroblastoma presents a more serious challenge. About 50-60% of patients fall into this high-risk category, and despite aggressive treatment approaches, the outlook remains more uncertain.[9] High-risk disease is often characterized by the presence of certain genetic features, such as MYCN amplification, which means extra copies of a gene that drives cancer cell growth. Approximately 25% of neuroblastoma patients have this amplification, and it is associated with poorer outcomes.[3]
Statistics about survival can feel cold and impersonal when you’re facing this diagnosis with your own child. It’s important to understand that every child’s situation is unique, and advances in treatment continue to improve outcomes. Between 1975 and 2020, overall survival rates for children with neuroblastoma have increased substantially, from 52% to 74%.[9] For children aged 1 to 14 years, the five-year survival rate improved from 34% to 83% during that same time period.[7] These improvements reflect better understanding of the disease, more targeted treatments, and enhanced supportive care.
The location of the primary tumor also influences prognosis. Neuroblastomas most commonly develop in the adrenal glands, which sit on top of the kidneys, but they can also arise in nerve tissue along the spine, in the chest, neck, or pelvis.[1] Tumors in certain locations may be easier to remove surgically or may respond better to other treatments. The child’s response to initial therapy is carefully monitored, as how well the tumor shrinks with treatment provides important clues about the overall prognosis.
Natural Progression Without Treatment
Understanding how neuroblastoma would develop if left untreated helps explain why treatment is necessary in most cases. However, neuroblastoma is unique among cancers because it exhibits an unusual behavior in some very young patients. In certain babies, particularly those diagnosed before birth or in the first year of life, the tumor can spontaneously regress, meaning it shrinks and disappears completely without any medical intervention.[2] This remarkable phenomenon is rare in the cancer world and reflects the developmental nature of neuroblastoma, which arises from cells that normally mature into healthy nerve tissue during fetal development.
For tumors that do not spontaneously resolve, the natural progression depends heavily on the biological characteristics of the cancer cells. Low-risk neuroblastomas with favorable biology tend to grow slowly. Without treatment, these might eventually cause symptoms by pressing on nearby structures or organs, but they typically do not spread aggressively to distant parts of the body. However, even these seemingly less dangerous tumors usually require at least surgical removal to prevent future complications.
In contrast, untreated high-risk neuroblastoma follows a much more aggressive course. These tumors can grow rapidly and spread to multiple sites throughout the body. By the time of diagnosis, approximately 70 to 80% of children already have cancer that has spread beyond the original site.[2] The cancer commonly spreads to lymph nodes, bone marrow, bones, liver, and skin. In some cases, it may also reach the lungs or brain. This widespread distribution of cancer cells throughout the body is called metastatic disease, and it explains why many children require intensive treatment that targets cancer cells wherever they may be hiding.
As the disease progresses untreated, tumor growth can cause increasing symptoms depending on where the cancer is located. A tumor in the abdomen might continue to enlarge, causing a visibly swollen belly, pain, difficulty eating, or problems with bowel and bladder function. Tumors near the spine can press on spinal nerves, potentially leading to weakness, difficulty walking, or even paralysis. When cancer invades the bone marrow, it interferes with the production of normal blood cells, leading to anemia, increased infections, and bleeding problems. Bones affected by cancer become weakened and painful.
Without treatment intervention, high-risk neuroblastoma would ultimately prove fatal as cancer spreads and overwhelms vital organs. This underscores the importance of diagnosis and treatment. Even in cases where spontaneous regression is possible, close monitoring is essential to ensure that the tumor is actually shrinking rather than quietly progressing. Doctors use regular imaging scans and urine tests to track whether observed tumors are truly regressing or whether intervention is needed.
Possible Complications
Neuroblastoma and its treatment can lead to various complications that parents should be aware of. Some complications arise directly from the tumor itself, while others result from the intensive therapies needed to fight the cancer. Understanding these potential problems helps families recognize warning signs early and seek appropriate medical attention.
One of the immediate complications that can occur from the tumor itself involves compression of vital structures. When a neuroblastoma grows near the spinal cord, it can press against the delicate nerve tissue that runs through the spine. This compression can cause back pain, weakness in the legs, difficulty walking, or in severe cases, paralysis.[4] This is considered a medical emergency requiring urgent treatment to prevent permanent nerve damage. Similarly, tumors in the chest can press on the windpipe or blood vessels, causing breathing difficulties or problems with blood flow.
Some children develop a unusual condition called opsoclonus-myoclonus syndrome, which appears to be caused by the immune system’s reaction to the tumor. This syndrome causes rapid, jerky eye movements that cannot be controlled, along with uncoordinated, jerky muscle movements throughout the body.[7] Children with this complication may have difficulty with balance and coordination. While this syndrome sometimes improves after the tumor is treated, some children continue to experience symptoms that require long-term management.
High blood pressure is another complication that can occur with neuroblastoma, particularly when tumors affect the kidneys or produce certain hormones. Some neuroblastoma cells make substances that cause the heart to beat faster and blood pressure to rise. Diarrhea can also occur when tumors produce specific substances that affect the digestive system.[4] These complications usually improve once the tumor is treated, but they may require medication management in the meantime.
Infections pose a significant risk during neuroblastoma treatment. Chemotherapy and other intensive treatments suppress the immune system, making it harder for the body to fight off bacteria, viruses, and fungi. Even minor infections can quickly become serious when a child’s white blood cell counts are low. Families must be vigilant about handwashing, avoiding crowds, and watching for fever or other signs of infection. Any fever during treatment should be reported to the medical team immediately, as it may require emergency antibiotics.
Bleeding problems can develop when the bone marrow is affected by cancer or suppressed by treatment. Platelets, the blood cells responsible for clotting, may drop to dangerously low levels. This can lead to easy bruising, nosebleeds, or in rare cases, more serious internal bleeding. Blood transfusions may be necessary to maintain safe levels of red blood cells and platelets during treatment.
Long-term complications, also called late effects, may not appear until months or years after treatment ends. These can include hearing loss from certain chemotherapy drugs, heart or kidney problems from intensive treatments, growth delays, hormonal imbalances, learning difficulties, and an increased risk of developing second cancers later in life.[21] Not every child experiences these late effects, but close monitoring is important throughout childhood and into adulthood. Regular follow-up visits with the oncology team allow early detection and management of any emerging problems.
Impact on Daily Life
Neuroblastoma diagnosis and treatment profoundly affect not just the child but the entire family’s daily life. The changes begin the moment of diagnosis and continue throughout treatment, recovery, and beyond. Understanding these impacts helps families prepare and develop coping strategies for the journey ahead.
The most immediate change involves the disruption to normal routines. Hospital stays, doctor appointments, and treatment sessions consume enormous amounts of time. For high-risk neuroblastoma, treatment typically lasts about 18 months and involves multiple phases, including chemotherapy, surgery, stem cell transplantation, radiation therapy, and immunotherapy.[15] Many of these treatments require hospitalization, sometimes for extended periods. The family’s life begins to revolve around the medical calendar, with normal activities like school, work, and social events taking a back seat to treatment schedules.
Physical limitations significantly impact the child’s daily activities. During intensive chemotherapy phases, children often feel exhausted, nauseated, and generally unwell. They may not have the energy for play, school, or activities they previously enjoyed. Hair loss, weight changes, and other visible side effects can affect how children feel about themselves, particularly in school-age children and teenagers who are becoming more aware of their appearance. Some children experience pain that limits their ability to move comfortably or participate in physical activities.
School attendance becomes irregular or impossible during active treatment. Children may miss an entire academic year or more. However, education doesn’t have to stop completely. Many hospitals have teachers on staff who work with hospitalized children. When children are well enough and their immune systems allow, they may attend school part-time or receive home tutoring. Staying connected with schoolwork when possible helps children maintain a sense of normalcy and keeps them from falling too far behind academically.
Social isolation presents another significant challenge. To protect children from infections when their immune systems are suppressed, families must limit contact with others. This means missing birthday parties, playdates, family gatherings, and other normal childhood social experiences. The isolation affects not just the sick child but also siblings, who may feel they’ve lost their normal family life and social opportunities. Some families find creative ways to stay connected through video calls, window visits, or carefully managed outdoor interactions.
Emotional and psychological impacts ripple through the entire family. Children with cancer often experience anxiety about procedures, fear about their illness, sadness about missing normal activities, and anger about their situation. Depending on their age, they may struggle to understand why this is happening to them.[19] Parents experience their own emotional turmoil, including grief, fear, helplessness, and sometimes guilt, even though nothing they did caused the cancer. Siblings may feel neglected, scared, or resentful about the attention their sick brother or sister receives.
Financial strain adds another layer of stress for many families. Even with insurance, medical costs can be substantial. Families may face copayments, deductibles, costs for travel to treatment centers, lodging near hospitals, and expenses for special foods or supplies. Often, one or both parents must reduce work hours or stop working entirely to care for their sick child. The loss of income combined with increased expenses creates significant financial pressure that compounds the emotional stress of dealing with cancer.
Despite these challenges, many families discover inner strength and develop effective coping strategies. Accepting help from others becomes essential. Friends, family members, and community organizations often want to help but may not know what to do. Being specific about needs—whether it’s meals, transportation, childcare for siblings, or help with household tasks—allows others to provide meaningful support. Many families benefit from connecting with other families going through similar experiences through support groups, either in person or online.
Maintaining some sense of routine, even modified, helps everyone cope better. Simple rituals like reading bedtime stories, watching favorite shows together, or having special snacks can provide comfort and normalcy. Allowing the sick child to make choices when possible—what to eat, what to wear, which toy to bring to the hospital—helps them maintain some sense of control in a situation where much is beyond their control.
Physical therapy and rehabilitation play important roles in helping children regain strength and function during and after treatment.[20] These services help children overcome developmental delays, recover from surgery, and rebuild energy levels. Mental health support, including counseling or therapy, can help both children and family members process their emotions and develop healthy coping mechanisms.
Nutrition deserves special attention, even though eating can be challenging during treatment. Well-nourished children tolerate treatment better and experience fewer delays.[25] When children struggle with appetite or nausea, offering frequent small meals of high-calorie, nutritious foods they find appealing works better than forcing traditional three meals a day. Avoiding empty calories from junk food while still being flexible about food preferences helps children get the nutrition they need without adding mealtime battles to an already stressful situation.
As treatment progresses and children begin feeling better, gradually reintroducing normal activities becomes important. This might start with short visits from friends, attending school for part of the day, or participating in gentle physical activities. The goal is to help the child feel like a child again, not just a cancer patient. With support, patience, and flexibility, families can navigate the challenges and maintain meaningful quality of life even during the most difficult phases of treatment.
Support for Family: Clinical Trials and How to Help
Clinical trials represent one of the most important ways that treatment for neuroblastoma continues to improve. Understanding what clinical trials are and how families can participate empowers parents to make informed decisions about their child’s care. Family members who want to support a child with neuroblastoma can also play crucial roles in helping navigate the clinical trial process.
A clinical trial is a carefully designed research study that tests new treatments or new ways of using existing treatments. These studies follow strict protocols to ensure patient safety while gathering information about whether new approaches are more effective than current standard treatments. For neuroblastoma, clinical trials might test new chemotherapy drugs, different combinations of existing drugs, novel immunotherapy approaches, targeted therapies that attack specific features of cancer cells, or supportive care strategies to reduce treatment side effects.
Parents sometimes worry that participating in a clinical trial means their child will receive inferior care or might get a placebo instead of real treatment. This is generally not how pediatric cancer trials work. In childhood cancer research, trials typically compare the current best treatment to a new approach that researchers believe might be even better. No child receives a placebo or “sugar pill” instead of active cancer treatment. The ethical standards governing pediatric cancer research are extremely rigorous, ensuring that every child enrolled receives quality care.
Clinical trials offer several potential benefits. Children in trials receive cutting-edge treatments that may not yet be available outside of research settings. They are monitored extremely carefully, with detailed attention to both treatment response and side effects. Some families find meaning in knowing that even if the experimental treatment doesn’t work perfectly for their child, the information gathered will help future children with neuroblastoma. Over the decades, it has been participation in clinical trials that has driven the dramatic improvements in survival rates for childhood cancers, including neuroblastoma.
Not every child is eligible for every clinical trial. Each trial has specific inclusion criteria that define which patients can participate, and exclusion criteria that list reasons why some patients cannot enroll. These criteria might include the child’s age, the stage and risk level of their disease, whether they’ve received previous treatment, and various health factors. The purpose of these criteria is to create groups of similar patients so that researchers can determine whether differences in outcomes are truly due to the treatment being tested rather than differences between patients.
Finding appropriate clinical trials requires some research and advocacy. The child’s oncology team is the best starting point for learning about available trials. Major children’s hospitals that treat neuroblastoma participate in cooperative research groups that conduct multi-center trials, meaning the same trial is running at many hospitals across the country or even internationally. The Children’s Oncology Group is the largest such organization studying childhood cancers in North America.
Families can also search for trials on their own using online databases. The U.S. government maintains a database at ClinicalTrials.gov where families can search for neuroblastoma studies by location, age, and other factors. Nonprofit organizations focused on neuroblastoma also maintain information about ongoing clinical trials and may help connect families with appropriate studies. When families find trials that sound promising, they can bring this information to their oncology team to discuss whether the trial might be appropriate for their child.
The decision to enroll in a clinical trial is deeply personal and should never feel pressured. Parents need time to understand what the trial involves, what the potential benefits and risks are, and how participation would affect their child’s daily life and treatment schedule. The process of informed consent ensures that families receive detailed information about the trial and have opportunities to ask questions before deciding whether to participate. For older children and teenagers, the assent process allows them to have a voice in the decision appropriate to their age and understanding.
Family members and friends who want to support the family through this journey can help in specific ways. Practical support often proves most valuable. This might include preparing meals, providing transportation to appointments, caring for siblings, helping with household chores, or assisting with errands. Financial support, whether direct help with expenses or organizing fundraisers, can ease the burden of medical and living costs.
Emotional support matters tremendously but can be tricky to provide well. Simply being present and listening without trying to fix everything or offer unsolicited advice helps parents feel less alone. Avoiding phrases like “everything happens for a reason” or “God doesn’t give you more than you can handle” is wise, as these often feel dismissive of the family’s pain. Instead, acknowledging that the situation is terrible and offering specific, concrete help tends to be more meaningful.
When it comes to clinical trials specifically, family members can help by assisting with research, helping organize and understand medical information, attending appointments to provide an extra set of ears, and helping the family think through decisions without pushing their own opinions. Some family members serve as advocates by connecting the family with resources, helping navigate insurance or financial issues, or simply handling phone calls and communications when parents are overwhelmed.
Respecting the family’s privacy and boundaries remains important throughout the journey. While family and friends naturally want updates and ways to help, families dealing with childhood cancer can become exhausted by constant questions and offers. Designating one family member to serve as a communication point or using online tools like CaringBridge to share updates can reduce this burden. The most helpful supporters are those who follow the family’s lead, offer specific help, follow through on commitments, and provide steady support over the long term rather than just during the initial crisis.
